Verus Capital Partners, LLC Invitae Corp Transaction History

Verus Capital Partners, LLC

  • $901 Million
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.42 - $0.72 $2,100 - $3,600
5,000 Added 22.48%
27,246 $17,000
Q3 2023

Nov 01, 2023
BUY
$0.6 - $1.53 $13,347 - $34,036
22,246 New
22,246 $13,000
Q1 2022

Aug 09, 2022
SELL
$6.28 - $15.59 $36,103 - $89,626
-5,749 Closed
0 $0
Q1 2020

May 26, 2020
SELL
$7.64 - $27.5 $7,067 - $25,437
-925 Reduced 13.86%
5,749 $79,000
Q4 2019

Feb 27, 2020
BUY
$15.02 - $20.57 $100,243 - $137,284
6,674 New
6,674 $108,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Verus Capital Partners, LLC Portfolio

Follow Verus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verus Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email